Liminal BioSciences Inc. LMNL

Deal for PBI1402 this week

[stockbuphoon]

Why did they give Pierre Laurin $400k upfront royalties on PBI1402 to "clean this up." Why now when they are pulling all of the 4050 indications from clinical trial planning? Is this not just a little suspicious that they would pay Pierre Laurin upfront cash on a deal for a failed drug? Is Thomvest bribing him so he doesnt talk in lawsuit? Any one a reason why this move was necessary now? It just doesn't make too much sense except cleaning up company IP for private sale after it runs out of money. The lack of an official press release regarding this move explains anything about it makes it even more suspicious. I guess Pritchard has to do something with his time. They gave up conference calls for 15 min each time. Does it seem like they are intentionally tanking this company for Thomvests benefit?

[Dibah420]

buphoon: You've asked some half a dozen questions here, some repeated in different words, but all questioning a $400k payment to PL.  Is it possible that you have overlooked a single, simple fact that answers ALL your questions?  That it was a LEGAL OBLIGATION under a pre-existing contract that the TV lawyers couldn't squirm out of? After all, if I wanted to bribe someone, there

[stockbuphoon]

Yes, I think you could be right but it seems suspicious in light of the timing now. Why is this important at this time? If there is no value in 4050, why would they even bother with precursor to 4050? It seems to be the perception that management has been trying to convey through shelving all indications and the wording of their press releases suggesting that they will continue to look for other